| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |